In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole/Colistin Combination Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates

被引：12
|
作者：
Su, Jiachun [1 ,2 ]
Li, Dan [1 ,2 ]
Guo, Qinglan [1 ,2 ]
Guo, Yan [1 ,2 ]
Zheng, Yonggui [1 ,2 ]
Xu, Xiaogang [1 ,2 ,3 ]
机构：
[1] Fudan Univ, Huashan Hosp, Inst Antibiot, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China
[2] Natl Hlth & Family Planning Commiss, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China
[3] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China
来源：
MICROBIAL DRUG RESISTANCE | 2019年 / 25卷 / 02期
关键词：
carbapenem-resistant Klebsiella pneumoniae; trimethoprim-sulfamethoxazole; colistin; bactericidal activity; COLISTIN; THERAPY;
D O I：
10.1089/mdr.2018.0085
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a formidable health challenge in recent years owing to the shortage of effective antibiotics. Colistin is the last and sometimes the only therapeutic option for CRKP infections. Unfortunately, resistance to colistin monotherapy is likely to develop. CRKP in China reportedly exhibit low rates of resistance to trimethoprim-sulfamethoxazole. The aim of this study was to evaluate the in vitro efficacy of trimethoprim-sulfamethoxazole in combination with colistin against four CRKP clinical isolates. The trimethoprim-sulfamethoxazole/colistin combination rapidly killed all four of the tested isolates after 2 h up to 24 h. Trimethoprim-sulfamethoxazole is one of the few remaining antimicrobials with some activity against CRKP. In particular, combined with colistin, trimethoprim-sulfamethoxazole might be promising for the treatment of CRKP infections.
引用
收藏
页码：152 / 156
页数：5
相关论文
共 50 条
  • [31] In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates
    Singkham-in, Uthaibhorn
    Chatsuwan, Tanittha
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 91 (02) : 169 - 174
  • [32] Resistome of carbapenem-and colistin-resistant Klebsiella pneumoniae clinical isolates
    Lomonaco, Sara
    Crawford, Matthew A.
    Lascols, Christine
    Timme, Ruth E.
    Anderson, Kevin
    Hodge, David R.
    Fisher, Debra J.
    Pillai, Segaran P.
    Morse, Stephen A.
    Khan, Erum
    Hughes, Molly A.
    Allard, Marc W.
    Sharma, Shashi K.
    PLOS ONE, 2018, 13 (06):
  • [33] Molecular detection of carbapenem-resistant genes in clinical isolates of Klebsiella pneumoniae
    Delarampour, A.
    Ghalehnoo, Z. R.
    Khademi, F.
    Delarampour, M.
    Vaez, H.
    ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITA, 2019, 31 (04): : 349 - 355
  • [34] Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae
    Liu, Peng
    Chen, Shuo
    Wu, Zhuo-ying
    Qi, Meng
    Li, Xiang-yang
    Liu, Cai-xia
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 238 - 243
  • [35] Efficacy of tigecycline-colistin combination in the treatment of carbapenem-resistant Klebsiella pneumoniae endocarditis
    Chaari, Anis
    Mnif, Basma
    Chtara, Kamilia
    Abid, Leila
    Charfeddine, Salma
    Baccouche, Najeh
    Bahloul, Mabrouk
    Hammami, Adnene
    Bouaziz, Mounir
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2015, 3 (03) : 214 - 216
  • [36] Colistin resistance in Carbapenem-resistant Klebsiella pneumoniae strains.
    Kalem, Fatma
    Ergun, Ayse Gul
    Ertugrul, Omur
    Ozcimen, Serap
    Simsek, Husniye
    Suzuk, Serap
    Unaldi, Ozlem
    Durmaz, Riza
    Arslan, Ugur
    BIOMEDICAL RESEARCH-INDIA, 2016, 27 (02): : 368 - 372
  • [37] Synergistic antibacterial activity of ceftazidime-avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae
    Tuzemen, Nazmiye Ulku
    Onal, Ugur
    Merdan, Osman
    Akca, Bekir
    Ener, Beyza
    Ozakin, Cuneyt
    Akalin, Halis
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [38] Heteroresistance Is Associated With in vitro Regrowth During Colistin Treatment in Carbapenem-Resistant Klebsiella pneumoniae
    Wang, Yifan
    Ma, Xinqian
    Zhao, Lili
    He, Yukun
    Yu, Wenyi
    Fu, Shining
    Ni, Wentao
    Gao, Zhancheng
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [39] Immunomodulatory effects of colistin on host responses against carbapenem-resistant Klebsiella pneumoniae biofilms
    Geladari, Anastasia
    Simitsopoulou, Maria
    Antachopoulos, Charalampos
    Roilides, Emmanuel
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (06)
  • [40] In vitro antimicrobial activity of colistin in combination with rifampicin against carbapenem-resistant Acinetobacter baumannii
    Kongsanae, K.
    Naenna, P.
    Dhiraputra, C.
    Leelarasamee, A.
    Pongpech, P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E421 - E422
12345